Bringing your ideas to life
In support of implantable technologies as diverse as cardiovascular devices, orthopedic implants, tissue regeneration scaffolds, and wound management systems, we offer you a proven family of resorbable polymers – supported by years of expertise across everything from contract manufacturing to custom synthesis.
When it comes to biomedical and resorbable polymers, our track record stretches back to the 1960s.
Today, our state-of-the-art GMP production, research and QA/QC facilities make us one of the most reliable large-scale (yet independent) partners to the industry.
Our PURASORB® family of resorbable polymers can be produced in batch sizes of 5kg up to over 100kg – across a broad range of different specifications. Our R&D laboratory includes a 2kg scale pilot facility, as well as a variety of equipment dedicated to the development and support of polymer compositions.
But our expertise isn’t limited to manufacturing: We also provide extended analytical services and analytical method development and validation.
Quality resorbable polymers for biomedical
We adhere strictly to all ICHQ7 guideline-based quality system, which form the basis of our processes and analytical methods.
This includes a Certificate of Analysis for every batch we produce, showing the analytical data determined in our quality control laboratory (with additional analytical data available on request).
We are ISO-9001: 2015 and ISO-14001:2015 certified and all our polymers and monomers are covered with a Device Master File (MAF 1961) and a Drug Master File (DMF 21817) filed at the FDA.
Most importantly, we allow customers to see this for themselves: They audit our facilities on a regular basis.
We adhere strictly to all ICHQ7 guideline-based quality system and our processes and analytical methods are validated accordingly
Product not available in your region
This product is not available in the selected region.
If you want this product in your region, or find a suitable alternative, please contact us,
Corbion General Shareholders Meeting approves Supervisory Board reappointments and dividend
The Corbion General Shareholders Meeting held on 13 May 2019 approved the reappointment of Jack
Corbion Introduces Clean Label Tortilla Conditioner
Corbion Introduces Clean-Label Tortilla Conditioner Tortilla Suave CL delivers high-end functionality without relying on conventional
DuPont Tate & Lyle Bio Products, Corbion, INOLEX, and ACT Solutions Collaborate to Create a Range of Personal Care Product Formulations Delivering High Performance and up to 100% Bio-based Content
Achieving High Performance and High Bio-based Content Formulations is Now a Reality New York, New
Plastic Future - Which sustainable future for plastics
Mons - Belgium | Today, 10 tons of plastic are produced all around the world... every second. While polymer-based
Clean Label Conference
Itasca, Illinois USA | Learn about just some of the ways we can help create clean-label success when we
Paris, France |